Gilead Sciences Inc. Delivers Deja Vu in the Fourth Quarter
The big biotech's fourth-quarter update sounded a lot like its third-quarter results, with continued HCV sales declines.
Wednesday, February 7, 2018
Gilead Sciences Inc. Delivers Deja Vu in the Fourth Quarter
Gilead Sciences Inc. Delivers Deja Vu in the Fourth Quarter
The big biotech's fourth-quarter update sounded a lot like its third-quarter results, with continued HCV sales declines.
0 comments:
Post a Comment